Ligand Appoints Pharmaceutical Executive Sarah Boyce to its Board of Directors

SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) (?Ligand? or ?the Company?) announces the appointment of Sarah Boyce to the Company’s Board of Directors, effective today. Ms. Boyce currently serves as President and CEO of Avidity Biosciences, Inc., a privately held biotechnology company pioneering the use of antibody-oligonucleotide conjugates (AOC?) to treat rare muscle disorders and other serious diseases. Ms. Boyce’s appointment increases the number of Ligand d